Published in Curr Cardiol Rep on November 01, 2007
ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science (2010) 4.67
Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol (2010) 4.08
Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib. Arterioscler Thromb Vasc Biol (2010) 1.69
ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis. Circ Res (2010) 1.37
Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study. PLoS Genet (2010) 1.11
Correlation of structural stability with functional remodeling of high-density lipoproteins: the importance of being disordered. Biochemistry (2008) 0.99
Hematopoietic stem/progenitor cell proliferation and differentiation is differentially regulated by high-density and low-density lipoproteins in mice. PLoS One (2012) 0.96
HDL anti-oxidant function associates with LDL level in young adults. Atherosclerosis (2013) 0.92
Protein expression profiles distinguish between experimental invasive pulmonary aspergillosis and Pseudomonas pneumonia. Proteomics (2010) 0.87
Long-term effects of acute low-dose ionizing radiation on the neonatal mouse heart: a proteomic study. Radiat Environ Biophys (2013) 0.85
Segregation of LIPG, CETP, and GALNT2 mutations in Caucasian families with extremely high HDL cholesterol. PLoS One (2012) 0.85
HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications. Front Pharmacol (2015) 0.80
Prevalence of persistent lipid abnormalities in statin-treated patients: Belgian results of the Dyslipidaemia International Study (DYSIS). Int J Clin Pract (2013) 0.79
Persistent dyslipidemia in Austrian patients treated with statins for primary and secondary prevention of atherosclerotic events - Results of the DYSlipidemia International Study (DYSIS). Wien Klin Wochenschr (2011) 0.78
Serum amyloid A impairs the antiinflammatory properties of HDL. J Clin Invest (2015) 0.78
The role of sphingolipid signalling in diabetes‑associated pathologies (Review). Int J Mol Med (2017) 0.75
Assessment of adiponectin level in obese and lean Nepalese population and its possible correlation with lipid profile: A cross-sectional study. Indian J Endocrinol Metab (2013) 0.75
Genetic and structure-function studies of missense mutations in human endothelial lipase. PLoS One (2013) 0.75
A Novel Anti-Inflammatory Effect for High Density Lipoprotein. PLoS One (2015) 0.75
Anti-inflammatory liaisons: T regulatory cells and HDL. J Lipid Res (2017) 0.75
Application of mass spectrometry to elucidate the pathophysiology of Encephalitozoon cuniculi infection in rabbits. PLoS One (2017) 0.75
Antiinflammatory properties of HDL. Circ Res (2004) 5.41
Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial. Circulation (2011) 3.01
ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol (2005) 2.46
Exercise capacity and stroke volume are preserved late after tetralogy repair, despite severe right ventricular dilatation. Heart (2012) 2.06
High-density lipoproteins enhance progenitor-mediated endothelium repair in mice. Arterioscler Thromb Vasc Biol (2006) 1.84
Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. J Am Coll Cardiol (2006) 1.84
Anti-inflammatory effects of apolipoprotein A-I in the rabbit. Atherosclerosis (2010) 1.76
Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes. Proc Natl Acad Sci U S A (2008) 1.71
What is so special about apolipoprotein AI in reverse cholesterol transport? Arterioscler Thromb Vasc Biol (2005) 1.61
Myocardial pathology in pulmonary thromboembolism. Heart (2011) 1.58
Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment. Clin Chem (2008) 1.56
Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial. Heart (2011) 1.55
Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion. Arterioscler Thromb Vasc Biol (2010) 1.55
Niacin inhibits vascular inflammation via the induction of heme oxygenase-1. Circulation (2011) 1.55
Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. J Am Coll Cardiol (2009) 1.53
Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation (2005) 1.53
Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I. Cardiovasc Res (2011) 1.51
Association of lower total bilirubin level with statin usage: the United States National Health and Nutrition Examination Survey 1999-2008. Atherosclerosis (2011) 1.50
Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome. Clin Sci (Lond) (2006) 1.47
Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk. J Lipid Res (2012) 1.46
High-density lipoproteins, inflammation and oxidative stress. Clin Sci (Lond) (2009) 1.43
Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo. Clin Endocrinol (Oxf) (2006) 1.42
Use of cardiac MR imaging to evaluate the presence of myocarditis in autoimmune myositis: three cases. Rheumatol Int (2010) 1.41
Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome? Arterioscler Thromb Vasc Biol (2007) 1.30
Molecular basis of PCSK9 function. Atherosclerosis (2008) 1.29
Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein. Nat Chem Biol (2012) 1.27
ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro. J Neurochem (2008) 1.20
The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro. Arterioscler Thromb Vasc Biol (2009) 1.19
Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation. J Biol Chem (2004) 1.17
The emerging role of HDL in glucose metabolism. Nat Rev Endocrinol (2012) 1.17
High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo. Arterioscler Thromb Vasc Biol (2010) 1.16
Cholesterol metabolism and pancreatic beta-cell function. Curr Opin Lipidol (2009) 1.16
Evidence that niacin inhibits acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids. Arterioscler Thromb Vasc Biol (2010) 1.15
Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells. Curr Opin Lipidol (2002) 1.09
Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation. J Biol Chem (2006) 1.08
Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration. Biochem Pharmacol (2006) 1.07
Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I. Arterioscler Thromb Vasc Biol (2010) 1.06
Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol (2007) 1.06
Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo. Atherosclerosis (2007) 1.05
Improvement in left ventricular filling properties after relief of right ventricle to pulmonary artery conduit obstruction: contribution of septal motion and interventricular mechanical delay. Eur Heart J (2009) 1.05
High-density lipoproteins neutralize C-reactive protein proinflammatory activity. Circulation (2004) 1.04
Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy. J Lipid Res (2010) 1.04
High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics. J Clin Endocrinol Metab (2005) 1.03
Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins. Atherosclerosis (2008) 1.03
Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa. Atherosclerosis (2007) 1.02
Relationship between the concentration and antiatherogenic activity of high-density lipoproteins. Curr Opin Lipidol (2006) 1.02
Arthritis: its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008. Ann Epidemiol (2012) 1.01
Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism? Circulation (2006) 1.01
Annexin A6 stimulates the membrane recruitment of p120GAP to modulate Ras and Raf-1 activity. Oncogene (2005) 1.01
Retracted Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control study. J Am Coll Cardiol (2012) 1.01
Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol (2005) 1.01
HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis. Arterioscler Thromb Vasc Biol (2009) 0.99
Antiinflammatory actions of HDL: a new insight. Arterioscler Thromb Vasc Biol (2008) 0.99
Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels. Diabetes Care (2007) 0.99
MicroRNAs in the onset and development of cardiovascular disease. Clin Sci (Lond) (2014) 0.98
Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: Where are we now? Trends Pharmacol Sci (2011) 0.97
Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids. Biochemistry (2003) 0.96
Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux. J Biol Chem (2004) 0.95
The low resolution structure of ApoA1 in spherical high density lipoprotein revealed by small angle neutron scattering. J Biol Chem (2011) 0.95
Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice. J Lipid Res (2007) 0.93
Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I. J Cell Mol Med (2009) 0.93
Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats. J Am Coll Cardiol (2008) 0.93
Isoform-specific proteolysis of apolipoprotein-E in the brain. Neurobiol Aging (2009) 0.92
Plasma proprotein convertase subtilisin/kexin type 9: a marker of LDL apolipoprotein B-100 catabolism? Clin Chem (2009) 0.90
The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins. Atherosclerosis (2011) 0.89
Characterisation of IL-22 and interferon-gamma-inducible chemokines in human carotid plaque. Int J Cardiol (2011) 0.89
Inhibition of mitogen-activated protein kinase Erk1/2 promotes protein degradation of ATP binding cassette transporters A1 and G1 in CHO and HuH7 cells. PLoS One (2013) 0.89
Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl). Biochem J (2013) 0.89
Reconstituted high-density lipoprotein attenuates postinfarction left ventricular remodeling in rats. Atherosclerosis (2008) 0.88
Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice. J Lipid Res (2008) 0.88
Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts. Free Radic Res (2009) 0.87
Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation. Atherosclerosis (2006) 0.87
Metabolism of apoA-I as lipid-free protein or as component of discoidal and spherical reconstituted HDLs: studies in wild-type and hepatic lipase transgenic rabbits. Arterioscler Thromb Vasc Biol (2002) 0.87
Are we lowering LDL cholesterol sufficiently? Nat Clin Pract Cardiovasc Med (2006) 0.87
Inhibition of H-Ras and MAPK is compensated by PKC-dependent pathways in annexin A6 expressing cells. Cell Signal (2005) 0.86
Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro. Biochemistry (2005) 0.86
Apolipoproteins regulate the kinetics of endothelial lipase-mediated hydrolysis of phospholipids in reconstituted high-density lipoproteins. Biochemistry (2004) 0.86
Apolipoprotein E activates the low-activity form of human phospholipid transfer protein. Biochem Biophys Res Commun (2005) 0.85
Trends in C-reactive protein levels in US adults from 1999 to 2010. Am J Epidemiol (2013) 0.85
Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes. J Clin Endocrinol Metab (2012) 0.85
High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-Δ24 reductase expression and inducing heme oxygenase-1. Circ Res (2012) 0.85
Homocysteine and cardiovascular disease: is HDL the link? Circ Res (2006) 0.84
Normalization of low-density lipoprotein receptor expression in receptor defective homozygous familial hypercholesterolemia by inhibition of PCSK9 with alirocumab. J Am Coll Cardiol (2014) 0.84
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia (2014) 0.83
Inhibition of arthritis in the Lewis rat by apolipoprotein A-I and reconstituted high-density lipoproteins. Arterioscler Thromb Vasc Biol (2013) 0.83
High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation. J Lipid Res (2013) 0.83
Implantable devices and magnetic resonance imaging. Heart Lung Circ (2012) 0.82
ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance. Atherosclerosis (2012) 0.81
Age related inflammatory characteristics of coronary artery disease. Int J Cardiol (2010) 0.81
POPC/apoA-I discs as a potent lipoprotein modulator in Tangier disease. Atherosclerosis (2007) 0.81
Dietary sphingomyelin lowers hepatic lipid levels and inhibits intestinal cholesterol absorption in high-fat-fed mice. PLoS One (2013) 0.80
Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit. J Lipid Res (2005) 0.80
Ras/mitogen-activated protein kinase (MAPK) signaling modulates protein stability and cell surface expression of scavenger receptor SR-BI. J Biol Chem (2011) 0.80
Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages. Arterioscler Thromb Vasc Biol (2011) 0.80
Effects of reconstituted HDL on charge-based LDL subfractions as characterized by capillary isotachophoresis. J Lipid Res (2007) 0.79
Analysis of apolipoprotein E nuclear localization using green fluorescent protein and biotinylation approaches. Biochem J (2008) 0.79
Relationship between atorvastatin dose and the harm caused by torcetrapib. J Lipid Res (2012) 0.79
Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages. PLoS One (2013) 0.79
Apolipoprotein E enhances hepatic lipase-mediated hydrolysis of reconstituted high-density lipoprotein phospholipid and triacylglycerol in an isoform-dependent manner. Biochemistry (2004) 0.79